PFE Competitors & Alternatives
Compare Pfizer Inc with similar stocks in the same industry
Drug Manufacturers - General
PFE
Main Stock$24.32
Tradestie Score
60
Market Cap
$154.70B
P/E Ratio
18.2
Revenue Growth
0.1%
Analyst Upside
+19.9%
Top Competitors
19 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AZN
AstraZeneca PLC
|
$195.15
|
$261.56B | 29.2 | 62 | Compare |
|
NVS
Novartis AG
|
$159.90
|
$254.99B | 22.1 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$129.56
|
$225.13B | 35.3 | 62 | Compare |
|
VZ
Verizon Communications
|
$42.56
|
$184.80B | 10.2 | 59 | Compare |
|
AMGN
Amgen Inc
|
$374.15
|
$160.70B | 25.1 | 69 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.27
|
$137.92B | 17.2 | 67 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$43.16
|
$121.27B | 18.4 | 56 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$58.13
|
$96.54B | 15.8 | 63 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$53.66
|
$91.59B | 13.7 | 66 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$216.12
|
$22.61B | 22.6 | 67 | Compare |
More PFE Analysis
Data updated: Jul 03, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
19 stocks in this industry